secwatch / observer
8-K filed April 26, 2024, 7:59 PM ET ticker SNTI CIK 0001854270
leadership confidence high sentiment neutral materiality 0.60

Senti Bio CFO Deborah Knobelman resigns; search for interim CFO underway

Senti Biosciences, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Deborah Knobelman

Chief Financial Officer, Treasurer and Head of Corporate Development
SNTI · Senti Biosciences, Inc.
Effective
2024-05-03
Filed
April 26, 2024, 7:59 PM ET
On April 23, 2024, Deborah Knobelman, Ph.D., the Chief Financial Officer, Treasurer and Head of Corporate Development of Senti Biosciences Inc. (“the Company”) and its principal financial officer and principal accounting officer, notified the Company of her decision to resign from her employment with the Company, effective May 3, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Deborah Knobelman resigned as Chief Financial Officer, Treasurer and Head of Corporate Development at Senti Biosciences, Inc..

Action
resigned
Role
Chief Financial Officer, Treasurer and Head of Corporate Development
Exact text from the filing
On April 23, 2024, Deborah Knobelman, Ph.D., the Chief Financial Officer, Treasurer and Head of Corporate Development of Senti Biosciences Inc. (“the Company”) and its principal financial officer and principal accounting officer, notified the Company of her decision to resign from her employment with the Company, effective May 3, 2024.
View on SEC.gov

Senti Biosciences, Inc. filing history →

Source: SEC EDGAR
accession 0001854270-24-000036
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.